Methods for treating conditions mediated by the inflammatory cytokine cascade using GAPDH inhibitors

Details for Australian Patent Application No. 2010286971 (hide)

Owner The Feinstein Institute for Medical Research

Inventors Tracey, Kevin J.; Parrish, William

Agent Shelston IP

Pub. Number AU-A-2010286971

PCT Pub. Number WO2011/025524

Priority 61/275,199 26.08.09 US

Filing date 17 August 2010

Wipo publication date 3 March 2011

International Classifications

A01N 37/18 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids - containing the group CON, e.g. carboxylic acid amides or imides

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

19 April 2012 PCT application entered the National Phase

  PCT publication WO2011/025524 Priority application(s): WO2011/025524

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010286985-Lithium-iron disulfide cathode formulation having high pyrite content and low conductive additives

2010286968-Flexible deep tissue temperature measurement devices